Selected research
Industry Research
Serum Biomarkers Industry Research Report 2026
Market perspective
The global Serum Biomarkers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Serum Biomarkers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Serum Biomarkers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Serum Biomarkers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Serum Biomarkers include Abbott, Novartis, Merck, Roche, Eli Lilly, Pfizer, AstraZeneca, Novo Nordisk and Gilead, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Serum Biomarkers market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Serum Biomarkers Market by Company
Abbott
Novartis
Merck
Roche
Eli Lilly
Pfizer
AstraZeneca
Novo Nordisk
Gilead
Bristol-Myers Squibb
Boehringer Ingelheim
BD
Allergan
Agilent Technologies
Serum Biomarkers Segment by Type
Lung Cancer Serum Biomarkers
Hepatocellular Carcinoma Serum Biomarkers
Glioblastoma Serum Biomarkers
Breast Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Others
Serum Biomarkers Segment by Application
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
Serum Biomarkers Segment by Region
North America
United States
Canada
Europe
v
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Serum Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum Biomarkers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Serum Biomarkers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Serum Biomarkers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Serum Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lung Cancer Serum Biomarkers
- Hepatocellular Carcinoma Serum Biomarkers
- Glioblastoma Serum Biomarkers
- Breast Cancer Serum Biomarkers
- Pancreatic & Biliary Tract Cancer Serum Biomarkers
- Others
Applications
- Hospitals
- Academic & Research Institutes
- Ambulatory Surgical Centers
- Others
Companies covered
- Abbott
- Novartis
- Merck
- Roche
- Eli Lilly
- Pfizer
- AstraZeneca
- Novo Nordisk
- Gilead
- Bristol-Myers Squibb
- Boehringer Ingelheim
- BD
- Allergan
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Serum Biomarkers Market Size (2021-2032)
- 2.2.2 Global Serum Biomarkers Sales (2021-2032)
- 2.2.3 Global Serum Biomarkers Market Average Price (2021-2032)
- 2.3 Serum Biomarkers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lung Cancer Serum Biomarkers
- 2.3.3 Hepatocellular Carcinoma Serum Biomarkers
- 2.3.4 Glioblastoma Serum Biomarkers
- 2.3.5 Breast Cancer Serum Biomarkers
- 2.3.6 Pancreatic & Biliary Tract Cancer Serum Biomarkers
- 2.3.7 Others
- 2.4 Serum Biomarkers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Academic & Research Institutes
- 2.4.4 Ambulatory Surgical Centers
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Serum Biomarkers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Serum Biomarkers Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Serum Biomarkers Revenue of Manufacturers (2021-2026)
- 3.4 Global Serum Biomarkers Average Price by Manufacturers (2021-2026)
- 3.5 Global Serum Biomarkers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Serum Biomarkers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Serum Biomarkers, Product Type & Application
- 3.8 Global Manufacturers of Serum Biomarkers, Established Date
- 3.9 Global Serum Biomarkers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Serum Biomarkers Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Serum Biomarkers Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Serum Biomarkers Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Roche
- 4.4.1 Roche Company Information
- 4.4.2 Roche Business Overview
- 4.4.3 Roche Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Serum Biomarkers Product Portfolio
- 4.4.5 Roche Recent Developments
- 4.5 Eli Lilly
- 4.5.1 Eli Lilly Company Information
- 4.5.2 Eli Lilly Business Overview
- 4.5.3 Eli Lilly Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Eli Lilly Serum Biomarkers Product Portfolio
- 4.5.5 Eli Lilly Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Serum Biomarkers Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 AstraZeneca
- 4.7.1 AstraZeneca Company Information
- 4.7.2 AstraZeneca Business Overview
- 4.7.3 AstraZeneca Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AstraZeneca Serum Biomarkers Product Portfolio
- 4.7.5 AstraZeneca Recent Developments
- 4.8 Novo Nordisk
- 4.8.1 Novo Nordisk Company Information
- 4.8.2 Novo Nordisk Business Overview
- 4.8.3 Novo Nordisk Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novo Nordisk Serum Biomarkers Product Portfolio
- 4.8.5 Novo Nordisk Recent Developments
- 4.9 Gilead
- 4.9.1 Gilead Company Information
- 4.9.2 Gilead Business Overview
- 4.9.3 Gilead Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Gilead Serum Biomarkers Product Portfolio
- 4.9.5 Gilead Recent Developments
- 4.10 Bristol-Myers Squibb
- 4.10.1 Bristol-Myers Squibb Company Information
- 4.10.2 Bristol-Myers Squibb Business Overview
- 4.10.3 Bristol-Myers Squibb Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol-Myers Squibb Serum Biomarkers Product Portfolio
- 4.10.5 Bristol-Myers Squibb Recent Developments
- 4.11 Boehringer Ingelheim
- 4.11.1 Boehringer Ingelheim Company Information
- 4.11.2 Boehringer Ingelheim Business Overview
- 4.11.3 Boehringer Ingelheim Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Boehringer Ingelheim Serum Biomarkers Product Portfolio
- 4.11.5 Boehringer Ingelheim Recent Developments
- 4.12 BD
- 4.12.1 BD Company Information
- 4.12.2 BD Business Overview
- 4.12.3 BD Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BD Serum Biomarkers Product Portfolio
- 4.12.5 BD Recent Developments
- 4.13 Allergan
- 4.13.1 Allergan Company Information
- 4.13.2 Allergan Business Overview
- 4.13.3 Allergan Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Allergan Serum Biomarkers Product Portfolio
- 4.13.5 Allergan Recent Developments
- 4.14 Agilent Technologies
- 4.14.1 Agilent Technologies Company Information
- 4.14.2 Agilent Technologies Business Overview
- 4.14.3 Agilent Technologies Serum Biomarkers Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Agilent Technologies Serum Biomarkers Product Portfolio
- 4.14.5 Agilent Technologies Recent Developments
5 Global Serum Biomarkers Market Scenario by Region
- 5.1 Global Serum Biomarkers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Serum Biomarkers Sales by Region: 2021-2032
- 5.2.1 Global Serum Biomarkers Sales by Region: 2021-2026
- 5.2.2 Global Serum Biomarkers Sales by Region: 2027-2032
- 5.3 Global Serum Biomarkers Revenue by Region: 2021-2032
- 5.3.1 Global Serum Biomarkers Revenue by Region: 2021-2026
- 5.3.2 Global Serum Biomarkers Revenue by Region: 2027-2032
- 5.4 North America Serum Biomarkers Market Facts & Figures by Country
- 5.4.1 North America Serum Biomarkers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Serum Biomarkers Sales by Country (2021-2032)
- 5.4.3 North America Serum Biomarkers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Serum Biomarkers Market Facts & Figures by Country
- 5.5.1 Europe Serum Biomarkers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Serum Biomarkers Sales by Country (2021-2032)
- 5.5.3 Europe Serum Biomarkers Revenue by Country (2021-2032)
- 5.5.4 v
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Serum Biomarkers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Serum Biomarkers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Serum Biomarkers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Serum Biomarkers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Serum Biomarkers Market Facts & Figures by Country
- 5.7.1 South America Serum Biomarkers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Serum Biomarkers Sales by Country (2021-2032)
- 5.7.3 South America Serum Biomarkers Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Serum Biomarkers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Serum Biomarkers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Serum Biomarkers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Serum Biomarkers Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Serum Biomarkers Sales by Type (2021-2032)
- 6.1.1 Global Serum Biomarkers Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Serum Biomarkers Sales Market Share by Type (2021-2032)
- 6.2 Global Serum Biomarkers Revenue by Type (2021-2032)
- 6.2.1 Global Serum Biomarkers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Serum Biomarkers Revenue Market Share by Type (2021-2032)
- 6.3 Global Serum Biomarkers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Serum Biomarkers Sales by Application (2021-2032)
- 7.1.1 Global Serum Biomarkers Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Serum Biomarkers Sales Market Share by Application (2021-2032)
- 7.2 Global Serum Biomarkers Revenue by Application (2021-2032)
- 7.2.1 Global Serum Biomarkers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Serum Biomarkers Revenue Market Share by Application (2021-2032)
- 7.3 Global Serum Biomarkers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Serum Biomarkers Value Chain Analysis
- 8.1.1 Serum Biomarkers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Serum Biomarkers Production Mode & Process
- 8.2 Serum Biomarkers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Serum Biomarkers Distributors
- 8.2.3 Serum Biomarkers Customers
9 Global Serum Biomarkers Analyzing Market Dynamics
- 9.1 Serum Biomarkers Industry Trends
- 9.2 Serum Biomarkers Industry Drivers
- 9.3 Serum Biomarkers Industry Opportunities and Challenges
- 9.4 Serum Biomarkers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst